|
02 February, 2015
|
ICON to Acquire MediMedia Pharma Solutions
|
|
|
06 November, 2014
|
ICON Selected by the FDA to Develop New Patient-Reported Outcome Measure for Hospital-Acquired Bacterial Pneumonia Trials
|
|
|
22 October, 2014
|
ICON Reports Third Quarter 2014 and Increases Earnings Guidance
|
|
|
19 September, 2014
|
ICON Plc Announces Completion of $40 Million Share Buyback and a Further Share Buyback Program for up to $100 Million
|
|
|
01 August, 2014
|
ICON: Pfizer and Roche Join ADDPLAN DF Consortium
|
|
|
30 July, 2014
|
ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
|
|
|
30 July, 2014
|
ICON Reports Second Quarter 2014 and Increases Earnings Guidance
|
|
|
09 May, 2014
|
ICON to Webcast Analyst Day Meeting
|
|
|
08 May, 2014
|
ICON Completes Acquisition of Aptiv Solutions
|
|
|
30 April, 2014
|
ICON Announces Appointment of Dr. Hugh Brady to Board of Directors
|
|
|
30 April, 2014
|
ICON Reports First Quarter 2014
|
|
|
31 March, 2014
|
ICON to Acquire Aptiv Solutions
|
|
|
20 February, 2014
|
ICON Announces Appointment of Ms. Mary Pendergast to Board of Directors
|
|
|
20 February, 2014
|
ICON Reports Fourth Quarter 2013 Revenue of $345 million, up 15% year on year and EPS of 53c, up 56% year on year. Full Year 2013 Revenue was $1.34 billion, up 20% year on year, EPS was $1.77 up 77% year on year. Guidance issued for 2014.
|
|
|
09 January, 2014
|
ICON Appoints Dr. Steve Cutler as Chief Operating Officer
|
|
|
24 October, 2013
|
ICON Reports Third Quarter 2013 Revenue of $340 Million, up 19% Year on Year, EPS of 45C and Raises FY 2013 Guidance.
|
|
|
09 October, 2013
|
ICON Launches New Patient Safety Service for Real-time Analysis of Aggregated Safety Data
|
|
|
25 July, 2013
|
ICON Reports second quarter 2013 Revenue of $334 million, up 21% year on year, non-GAAP EPS of 43c and raises FY 2013 Guidance.
|
|
|
23 July, 2013
|
ICON shareholders vote in favour of all resolutions at its Annual General Meeting
|
|
|
25 April, 2013
|
ICON Reports First Quarter 2013 Revenue of $317 Million, up 26% year on year and non-GAAP EPS of 36c.
|
|
